Skip to main content

Epicardial fat thickness among neonates of diabetic mothers attending the neonatal intensive care unit at Fayoum University Hospital: a case control study

Abstract

Background

Using conventional echocardiography, this study aimed to evaluate the epicardial fat thickness (EFT) and its role in discriminating infants of diabetic mothers (IDMs) from those of non-diabetic mothers (INDMs) and to assess its prognostic role in IDMs. This case control study was conducted at the Neonatology and Cardiology Units of Pediatric Department, Fayoum University Hospital, Egypt, between February and September 2023. A total of 54 neonates were enrolled into three groups: 18 IDMs with well-controlled diabetes mellitus (DM), 18 IDMs with poorly controlled DM, and 18 INDMs.

Results

The sensitivity, specificity, and cutoff of EFT were 100%, 100%, and 3.950 mm for detecting cases of IDMs and were 66.7%, 72.2%, and 5.100 mm for differentiating controlled from uncontrolled diabetic mothers, respectively. The interventricular septum in diastole (IVSd), interventricular septum in systole (IVSs), estimated pulmonary artery pressure (PAP), left ventricle (LV) Tei index, and isovolumetric relaxation time (IVRT) of LV all showed a positive correlation with EFT (r = 0.35, 0.31, 0.41, 0.34, and 0.39; P = 0.009, 0.025, 0.002, 0.01, and 0.003; respectively). There was a significant negative correlation between EFT and left ventricular internal dimensions in diastole (LVIDd) and left ventricular internal dimensions in systole (LVIDs) (r =  − 0.44 and 0.42, P = 0.001 and 0.001). Regarding tissue Doppler, there was a significantly higher Tei index in group I cases compared to control (0.59 ± 0.10 vs. 0.49 ± 0.09, P < 0.001).

Conclusions

The EFT is higher in IDMs than in INDMs, with a positive correlation with birth weight, IVSd, IVSs, Tei index of mitral, IVRT, and ESPAP and a negative correlation with LVIDd and LVIDs. Neonatal EFT can be used as one of the helpful parameters to detect IDMs. Also, it may be used as one of the prognostic factors in IDMs as it is positively correlated with the diastolic function of the LV.

Background

Diabetes necessitates ongoing medical care and risk reduction strategies, beyond glucose management. Self-management education and support are crucial for preventing acute and long-term complications [1].

The term “gestational diabetes mellitus” (GDM) describes varied degrees of glucose intolerance that initially appears during pregnancy. The entire etiopathogenesis of the illness is still unknown. Along with obesity, genetics, and environmental factors, inflammatory factors leading to insulin resistance and dysfunction triggered by placental hormones play a major role in the etiopathogenesis of the disease [2].

Maternal hyperglycemia during the first trimester might result in significant birth abnormalities such truncus arteriosus or aortic coarctation or spontaneous abortions. Maternal hyperglycemia during the second and third trimesters can result in hyperglycemia and hyperinsulinemia in the fetus. These conditions can also produce hypocalcemia, polycythemia, hyperbilirubinemia, septal cardiac hypertrophy, delayed lung maturation, and macrosomia in the neonate [3].

Physicians generally advise patients to maintain optimal glycemic control prior to conception and during the first few months of pregnancy, but few people actually do so. During the organogenesis phase of pregnancy, hemoglobin A1c levels obtained in the first half of the pregnancy can serve as a marker for average blood glucose levels [4].

It has been demonstrated that fetal metabolism is impacted by maternal metabolic illness. The fetuses of mothers with diabetes exhibit modified adiposity, elevated insulin resistance, inflammation, and hematological alterations that are indicative of chronic hypoxia [5].

Echocardiography can measure the thickness of epicardial adipose tissue (EAT), an emerging cardiometabolic risk factor. It is still unclear how EAT and the metabolic syndrome are related [6].

There have been reports of asymmetrical septal hypertrophy and hypertrophic cardiomyopathy (HCM) in newborns of diabetes mothers due to the stimulation of their hearts by insulin and other growth hormones. Moreover, epicardial fat is an early contributor to the diastolic function, similar to an alteration in HCM [7].

The need for markers to predict gestational diabetes mellitus (GDM) and its associated perinatal complications is growing, with fetal adipose tissue increase most frequently in the third trimester [8]. Therefore, the aim of this study was to evaluate epicardial fat thickness and its role in discriminating infants of diabetic mothers from those of non-diabetic mothers and to assess its prognostic role in these infants.

Methods

This case control study was conducted in the Neonatology and Cardiology Units of the Pediatric Department at El-Fayoum University Hospital, Fayoum, Egypt, from February to September 2023. The study included 54 neonates, who were divided into three groups: Group I, cases group included 18 neonates of well-controlled diabetic mothers (glycosylated hemoglobin [HbA1c] less than 7); Group II, cases group included 18 neonates of poorly controlled diabetic mothers (HbA1c greater than 7); and Group III, control group. This group included 18 neonates of healthy, non-diabetic mothers. The study groups were matched for sex and age. The inclusion criteria for participation in the study were neonates of diabetic and non-diabetic mothers of both sexes. Neonates with suspected chromosomal abnormalities were excluded from the study.

All the neonates underwent the following procedure:

  1. 1.

    Detailed history taking including gestational age, mode of delivery, maternal type of diabetes, history of neonatal intensive care unit (NICU) admission, history of jaundice, maternal illness other than diabetes, and history of respiratory distress.

  2. 2.

    Clinical assessment of the patient encompassing vital signs, recumbent length, weight, and head circumference in addition to a comprehensive general assessment (including any dysmorphic features). Additionally, neurological, cardiac, abdominal, and chest exams were carried out.

  3. 3.

    Investigations:

    • Laboratory investigations that prove the glycemic state of mothers of IDMs, including HBA1c.

    • Imaging investigations, including echocardiography (conventional echocardiography) and tissue Doppler imaging (TDI), were conducted within the first week of life. A General Electric Vivid 5-color Doppler ultrasound system with transducers operating at 3.75 MHz or 5 MHz, appropriate for infants, was used to perform echocardiography. A complete echocardiographic examination was performed. Using conventional echocardiography from the standard transthoracic windows: Parasternal long axis Transducer in cardiac M mode, left ventricular end diastolic diameter (LVEDD), LV end systolic diameter (LVESD), LV posterior wall (LVPW), and LV ejection fraction (EF) were measured [9].

    • Using pulsed wave Doppler imaging and transmitral E wave velocity (E) and (A) wave velocity were averaged to generate the mean value, and this was done by apical 4 chamber view on the mitral septal leaflet [9]. Myocardial velocity in systole, early diastole, and late diastole was measured using the TDI. The Tei index, also known as the global myocardial performance index, was calculated using tissue Doppler and pulsed tissue velocity imaging. By dividing the total isovolumic contraction and relaxation times by the ejection time, it can be defined [10].

      The region between the visceral layer of the pericardium and the outer wall of the myocardium that is echo-free has been named epicardial fat thickness (EFT). Using the aortic annulus as the anatomical landmark, the EFT was measured in the parasternal long axis view perpendicular to it [11].

All measurements were taken end systolic when the EFT was highest. The average value of three cardiac cycles was calculated.

Statistical methods

In order to make the manipulation easier, data were gathered and coded. After that, Microsoft Access was used to enter and analyze the data. The statistical package for the social sciences (SPSS) version 22 program was used to analyze the data on a Windows 7 computer (SPSS Inc., Chicago, IL, USA). The qualitative data were presented as numbers and percentages for a basic descriptive analysis, while the quantitative parametric data were summarized using standard deviations as measures of dispersion and arithmetic means as measures of central tendency. An independent sample t-test was employed in the analysis of quantitative data to compare quantitative measures between the two independent groups. The chi-square test was utilized to compare two or more qualitative groups in order to analyze the qualitative data. To examine the relationship between the variables, bivariate Pearson’s correlation tests were performed. Receiver operating characteristic (ROC) curves were used in sensitivity and specificity tests to evaluate the efficacy of a new test. At P < 0.05, statistical significance was established.

Ethics approval and consent to participate

This study was reviewed by the Ethics Committee of the Faculty of Medicine (Approval ID: M642). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consents were obtained from the participants’ legal guardians.

Results

We recruited 54 neonates who were divided into 3 groups: 18 neonates with IDMs with well controlled DM (HbA1c less than 7), 18 neonates of IDMs with poorly controlled DM (HbA1c greater than 7), and 18 healthy neonates of non-diabetic mothers. This case control study was conducted at the Neonatal and Cardiology Units of the Pediatric Department at Fayoum University Hospital, Fayoum, Egypt, between February and September 2023.

Our findings indicated that there was no statistically significant difference in mode of delivery or gestational age between cases and controls. As regards anthropometric measures, there was a statistically significant higher birth weight in both groups of cases when compared with the control (Table 1).

Table 1 Comparisons of demographic characteristics and anthropometric measures in different study groups

The mean of HBA1c in IDMs with well controlled DM was 6.37 ± 0.67; on the other hand, the mean of HBA1c in IDMs with poorly controlled DM was 7.73 ± 0.74, which is significantly different. There was no statistically significant difference with a P > 0.05 as regards types of diabetes (Table 2).

Table 2 Comparisons of demographic characters in different cases groups

As regards medical history among study groups, there was no statistically significant difference with a P value < 0.05 (Table 3).

Table 3 Comparisons of medical history in different study groups

In terms of echocardiographic findings, there was a statistically significant difference in IVSd, IVSs, LVIDd, and LVIDs levels between group I and group III and between groups II and III with a P < 0.05. As regards ESPAP level, there was a statistically significant difference with a P value of 0.01 between groups II and III, with a higher mean among group II. As regards the tissue Doppler finding, there was a statistically significant higher level of Tei of LV among group I in comparison to group III with a P value of 0.02 (Table 4).

Table 4 Comparisons of conventional Echocardiographic findings and tissue Doppler finding in different study groups

In terms of EFT, the mean was higher among group II, followed by group I, and the lowest level was in group III, which is statistically significant (Fig. 1).

Fig. 1
figure 1

Mean epicardial fat thickness in the study groups

Between EFT and neonatal birth weight, there was a statistically significant positive correlation (P value < 0.05) (r = 0.61, P = 0.001) (Fig. 2).

Fig. 2
figure 2

Correlation between epicardial fat thickness and birth weight

There was a statistically significant positive correlation with a P value < 0.05 between EFT and each of IVSd (r = 0.35, P = 0.009), IVSs (r = 0.31, P = 0.025), and ESPAP (r = 0.41, P = 0.002) measurements, and a significant negative correlation with LVIDd and LVIDs measurements. Additionally, a statistically significant correlation (P value < 0.05) was found between the EFT and Tei index of LV (r = 0.34, P = 0.01) and IVRT (r = 0 0.39, P = 0.03) (Table 5).

Table 5 Correlation between epicardial fat thickness and echo findings in different study groups

The sensitivity and specificity tests for EFT in the diagnosis of cases of diabetic mothers were 100% at a cutoff value of 3.950 mm, and for differentiation between controlled and uncontrolled diabetic mothers, the sensitivity was 66.7%, and the specificity was 72.2% at a cutoff value of 5.100 mm (Figs. 3 and 4).

Fig. 3
figure 3

Receiver operating characteristic curve for epicardial fat thickness in diagnosis of diabetic cases

Fig. 4
figure 4

Receiver operating characteristic curve for epicardial fat thickness in diagnosis of controlled and uncontrolled diabetic cases

Discussion

EFT has emerged as a new marker of cardiometabolic risk due to its intimate proximity with the myocardium, the coronary arteries, and its endocrine metabolic features [6].

The large visceral fat storage known as EFT is situated around the large coronary arteries and between the epicardium and pericardium. Through the cytokine pathway, this tissue contributes to the development of atherosclerosis and has significant endocrine and paracrine activity [12].

Maternal diabetes modifies the fetal environment, which causes more and earlier fat deposition in the epicardial fat compared to other fat stores [8].

In the current study, we found that IDMs have LV hypertrophy. They also have global myocardial dysfunction in comparison to healthy individuals using two dimensional conventional echocardiography and TDI. These findings are consistent with those reported by Farag et al. [13]. We found that IDM with poorly controlled diabetes has a significantly higher ESPAP in comparison to healthy individuals.

Chronic fetal hyperinsulinemia causes fetal macrosomia and increases the cardiac mass due to a larger mass of myocardial nuclei, an increase in the number of myocardial cells, and hypertrophy of myocardial fibers. There are more insulin receptors in the fetal heart, which makes it easier for protein and fat synthesis regardless of how much glycogen is deposited, which makes IDM more susceptible to HCM and increased LV dimensions [14].

We found that there was a statistically significant difference between study groups as regards EFT, with a higher mean among IDM patients with poorly controlled diabetes. It is followed by IDM with well controlled diabetes, and the lowest level was in healthy control. These findings agree with those of Vela-Huerta et al. [9] who reported the same findings. The altered fetal environment, including hyperinsulinemia and hyperglycemia resulting from maternal diabetes, results in greater and earlier fat deposition in epicardial fat than in other fat stores [8].

In the current study, EFT was positively correlated with neonatal birth weight. Similar to our findings, Jackson et al. [15] reported that in the fetuses of diabetic mothers, EFT correlates directly with both EFW and abdominal circumference. Both of these are previously validated sonographic markers of an adverse fetal response to the diabetic state.

The presence of hyperglycemia, hyperinsulinemia, and inflammatory processes enhances the placental supply of nutrients to the developing fetus, including not only glucose but also amino acids and free fatty acids, thereby exerting an impact on fetal growth, causing macrosomia, and fat deposition in the epicardial space, resulting in higher EFT [16].

Our study also showed that there was a statistically significant positive correlation between EFT and each of the IVSd, IVSs, and ESPAP measurements and a significant negative correlation with the LVIDd and LVIDs measurements. This agrees with the results reported by Vela-Huerta et al. [9].

Hypertrophic cardiomyopathy is a prevalent cardiac anomaly observed in around 40% of pregnancies affected by diabetes. Myocardial hypertrophy is distinguished by the augmentation of both the interventricular septum and ventricular walls [17] caused by an altered fetal environment regarding hyperglycemia and hyperinsulinemia, which are similar mechanisms attributed to higher EFT found in IDM [9].

Our study illustrated that there was a statistically significant positive correlation between EFT, each of IVRT, and Tei of LV. Similar to our findings, Ghandi et al. [18] found that there was a statistically higher incidence of diastolic dysfunction in cases of IDMs than in the healthy control group.

Underdeveloped fetal ventricular compliance and, as a result, diastolic dysfunction because of a thicker cardiac wall occurs in IDMS [19]. Increased epicardial fat mechanically affects LV and RV diastolic filling, causing diastolic dysfunction [11].

We found that the sensitivity and specificity test for EFT in the detection of cases of diabetic mothers was 100% at a cutoff value of 3.950 mm, and for differentiation between controlled and uncontrolled diabetic mothers, the sensitivity was 66.7% and the specificity was 72.2 at a cutoff value of 5.100 mm.

The main reason for EFT to be a reliable marker is that it is not affected by changes in subcutaneous and muscle tissues [20]. The altered fetal environment, including hyperinsulinemia and hyperglycemia resulting from maternal diabetes, results in greater and earlier fat deposition in epicardial fat than in other fat stores [8].

The limitations of the present study were the need for further studies with larger number of patients, and the need for long-term follow-up period to understand the etiology and clinical implications of the echocardiographic findings.

Conclusions

We concluded that the sensitivity and specificity tests for EFT in the detection of cases of diabetic mothers were 100% at a cutoff value of 3.950 mm, and for the differentiation of controlled from uncontrolled diabetic mothers, the sensitivity was 66.7% and the specificity was 72.2% at a cutoff value of 5.100 mm. EFT increases more in infants with elevated IVSd, IVSs, ESPAP, IVRT, and Tei index of mitral. There is a significant negative correlation with LVIDd and LVIDs measurements. Neonatal EFT can be used as one of the helpful parameters to detect IDMs. Also, it may be used as one of the prognostic factors in IDM as it is positively correlated with the diastolic function of the LV, so these neonates should be monitored closely.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

A:

A wave

AO:

Aortic root

BW:

Birth weight

E:

E wave

EAT:

Epicardial adipose tissue

EF:

Ejection fraction

EFT:

Epicardial fat thickness

ESPAP:

Estimated pulmonary artery pressure

ET:

Ejection time

FS:

Fraction shortening

GDM:

Gestational diabetes mellitus

HbA1c:

Glycosylated hemoglobin

HCM:

Hypertrophic cardiomyopathy

IDMs:

Infants of diabetic mothers

INDMs:

Infants of non-diabetic mothers

IVCT:

Isovolumic contraction time

IVRT:

Isovolumic relaxation time

IVSd:

Interventricular septum in diastole

IVSs:

Interventricular septum in systole

LVIDd:

Left ventricular internal dimensions in diastole

LVIDs:

Left ventricular internal dimensions in systole

LVPW:

Left ventricular posterior wall

MPI or Tei:

Myocardial performance index

TAPSE:

Tricuspid annular plane systolic excursion

References

  1. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes A (2023) 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 46:S19-s40. https://doi.org/10.2337/dc23-S002

    Article  CAS  PubMed  Google Scholar 

  2. Natamba BK, Namara AA, Nyirenda MJ (2019) Burden, risk factors and maternal and offspring outcomes of gestational diabetes mellitus (GDM) in sub-Saharan Africa (SSA): a systematic review and meta-analysis. BMC Pregnancy Childbirth 19:450. https://doi.org/10.1186/s12884-019-2593-z

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shou C, Wei Y-M, Wang C, Yang H-X (2019) Updates in long-term maternal and fetal adverse effects of gestational diabetes mellitus. Maternal-Fetal Med 1:91–94. https://doi.org/10.1097/fm9.0000000000000019

    Article  Google Scholar 

  4. Davis J, Heiselman C, Hoffmann E, Dinglas C, Vintzileos AM, Heo HJ (2019) Does 1st trimester hemoglobin A1c predict adverse pregnancy outcomes? [9E]. Obstet Gynecol 133:53S. https://doi.org/10.1097/01.AOG.0000559001.97048.d0

    Article  Google Scholar 

  5. Manerkar K, Harding J, Conlon C, McKinlay C (2020) Maternal gestational diabetes and infant feeding, nutrition and growth: a systematic review and meta-analysis. Br J Nutr 123:1201–1215. https://doi.org/10.1017/s0007114520000264

    Article  CAS  PubMed  Google Scholar 

  6. Villasante Fricke AC, Iacobellis G (2019) Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci 20. https://doi.org/10.3390/ijms20235989

  7. Pugliese NR, Paneni F, Mazzola M, De Biase N, Del Punta L, Gargani L, Mengozzi A, Virdis A, Nesti L, Taddei S, Flammer A, Borlaug BA, Ruschitzka F, Masi S (2021) Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail 23:1858–1871. https://doi.org/10.1002/ejhf.2337

    Article  CAS  PubMed  Google Scholar 

  8. Iskender C, Yakut Yücel K, Dereli ML, Sağlam E, Çelen Ş, Çağlar T, Engin-Üstün Y (2022) Increased fetal epicardial fat thickness: a reflecting finding for GDM and perinatal outcomes. Echocardiography 39:1082–1088. https://doi.org/10.1111/echo.15416

    Article  PubMed  Google Scholar 

  9. Vela-Huerta MM, Amador-Licona N, Domínguez-Damián R, Heredia-Ruiz A, Orozco-Villagomez HV, Guízar-Mendoza JM, Alarcon-Santos S (2022) Epicardial fat thickness in infants of diabetic mothers. J Neonatal Perinatal Med 15:75–80. https://doi.org/10.3233/npm-210787

    Article  CAS  PubMed  Google Scholar 

  10. Kaya H, Asoglu R, Afsin A, Tibilli H, Kurt E, Kafadar S, Gulacti U, Kafadar H (2022) Evaluation of myocardial performance index in patients with COVID-19: an echocardiographic follow-up study. Rev Port Cardiol 41:455–461. https://doi.org/10.1016/j.repc.2021.03.014

    Article  PubMed  PubMed Central  Google Scholar 

  11. Iacobellis G, Baroni MG (2022) Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat. J Endocrinol Invest 45:489–495. https://doi.org/10.1007/s40618-021-01687-1

    Article  CAS  PubMed  Google Scholar 

  12. Braescu L, Gaspar M, Buriman D, Aburel OM, Merce AP, Bratosin F, Aleksandrovich KS, Alambaram S, Mornos C (2022) The role and implications of epicardial fat in coronary atherosclerotic disease. J Clin Med 11. https://doi.org/10.3390/jcm11164718

  13. Farag MM, Marzouk IM, Abdel Mohsen AM, EAM R (2023) Echocardiographic findings in infants of diabetic mothers and their relation to maternal glycemic control. Alex J Pediatr 36:1–14. https://doi.org/10.4103/ajop.ajop_7_23

    Article  Google Scholar 

  14. Ramadan AM (2021) Echocrdiographic findings in infants of diabetic mothers and its relation to maternal glycemic control. Alexmed ePosters. 3:29–30. https://doi.org/10.21608/alexpo.2021.90244.1246

    Article  Google Scholar 

  15. Jackson D, Deschamps D, Myers D, Fields D, Knudtson E, Gunatilake R (2016) Fetal epicardial fat thickness in diabetic and non-diabetic pregnancies: a retrospective cross-sectional study. Obesity (Silver Spring) 24:167–171. https://doi.org/10.1002/oby.21353

    Article  CAS  PubMed  Google Scholar 

  16. Agudelo-Espitia V, Parra-Sosa BE, Restrepo-Mesa SL (2019) Factors associated with fetal macrosomia. Rev Saude Publica 53:100. https://doi.org/10.11606/s1518-8787.2019053001269

    Article  PubMed  PubMed Central  Google Scholar 

  17. Darwish A, Abdel-Raouf M, Kamel R, Salah E, Salah M, Okasha A (2022) Fetal echocardiographic parameters in pregnancies complicated by diabetes: a case control study. BMC Pregnancy Childbirth 22:650. https://doi.org/10.1186/s12884-022-04969-5

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ghandi Y, Habibi D, Nasri K, Alinejad S, Taherahmad H, Arjmand Shabestari A, Nematinejad A (2019) Effect of well-controlled gestational diabetes on left ventricular diastolic dysfunction in neonates. J Matern Fetal Neonatal Med 32:2101–2106. https://doi.org/10.1080/14767058.2018.1425832

    Article  PubMed  Google Scholar 

  19. Zablah JE, Gruber D, Stoffels G, Cabezas EG, Hayes DA (2017) Subclinical decrease in myocardial function in asymptomatic infants of diabetic mothers: a tissue Doppler study. Pediatr Cardiol 38:801–806. https://doi.org/10.1007/s00246-017-1584-y

    Article  PubMed  Google Scholar 

  20. Mastebhakti B, Garg S, Gupta N, Singh S, Aggarwal S, Singh R (2020) Epicardial adipose tissue thickness as a reliable marker of increased cardiovascular risk in patients with type 2 diabetes mellitus. J Endocrinol Metab 10:173–181

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

AA, RY, AS, and HB have full access to all the data in the study and take responsibility for the integrity of the data. Study concept and design: AA and HB. Acquisition of data: RY and AS. Analysis of data: HB and AA. Drafting of the manuscript: RY and AS. Critical revision of the manuscript: AA and HB. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Heba A. Borayek.

Ethics declarations

Ethics approval and consent to participate

This study was reviewed by the Ethics Committee of the Faculty of Medicine, Fayoum University, Egypt (Approval ID: M642). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consents were obtained from the participants’ legal guardians.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abd El Moktader, A.M., Yousef, R.M., Safwat, A. et al. Epicardial fat thickness among neonates of diabetic mothers attending the neonatal intensive care unit at Fayoum University Hospital: a case control study. Egypt Pediatric Association Gaz 72, 13 (2024). https://doi.org/10.1186/s43054-024-00254-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43054-024-00254-6

Keywords